To validate these data in IBD, we performed quantitative RT-PCR (RT-qPCR) assays to determine BRG1 expression in colonic biopsy specimens from CD and UC patients as well as from normal controls. This evidence concerns the gene SMARCA4 and inflammatory bowel disease.